Tous Actualités
Suivre
Abonner Marseille-Kliniken AG

Marseille-Kliniken AG

EANS-Adhoc: Marseille-Kliniken AG: Uwe Bergheim and Prof. Matthias Schönermark resign from the supervisory board

--------------------------------------------------------------------------------
  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
other/other/Resignation of two supervisory board members 
03.12.2012


Hamburg, 03 December 2012 - After the expiration of the annual general meeting
today, Messrs Uwe Bergheim and Prof. Dr. med. Matthias P. Schönermark have
resigned from the supervisory board of Marseille-Kliniken AG (ISIN DE0007783003,
WKN 778300, MKA). With this step they are following up their announcements of 19
October 2012.

end of ad-hoc-announcement
================================================================================
About Marseille-Kliniken AG:

Marseille-Kliniken AG (ISIN DE0007783003, WKN 778300, MKA) with its 57
residential care facilities, three residential units for assisted living and
about 4,800 employees is a market leading listed company on health care in
Germany. The business model is significantly influenced by the demographic
development. Therefore Marseille-Kliniken AG has a secured future. Short-term
economic fluctuations on the other hand exert only a minor influence. As a
consistently modern company with strong focus on quality, the private enterprise
is in a good position within a competitive environment primarily characterized
by regionally active charities.

Further inquiry note:
Hillermann Consulting
Jan Pahl
Investor Relations for Marseille-Kliniken AG
Poststraße 14-16
20354 Hamburg
Germany
Tel.: + 49 (0)40 / 3202791-0
www.marseille-kliniken.com

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


issuer:      Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
mail:         info@marseille-kliniken.de
WWW:         http://www.marseille-kliniken.de
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
             Hamburg, regulated dealing/prime standard: Frankfurt 
language:   English

Plus de actualités: Marseille-Kliniken AG
Plus de actualités: Marseille-Kliniken AG